Sisram Medical Announces 2024 Annual Results
New product launches drive double-digit growth in key markets and deliver market outperformance amid economic challenges
HONG KONG, March 19, 2025 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group, featuring a distinguished synergistic ecosystem of business building blocks and consumer-focused approaches including Energy-Based Devices (EBD), Injectables, alongside other complementary offerings, announced its audited consolidated annual results for the year ended December 31, 2024 (the "Reporting Period").
FINANCIAL HIGHLIGHTS
Revenue was US$349.1 million, representing a decrease of 2.8% YoY.
Gross profit margin was 62.1%, representing an increase of 1.0 percentage point from 61.1% in 2023.
Revenue portion derived from direct sales for the year ended December 31, 2024, was 87% of total revenue, as compared to 78% for the corresponding period in 2023. Revenues in Asia Pacific, European, Middle East and Africa were US$116.2 million, US$50.5 million, US$34.6 million, increased by 6.0%, 0.7%, and 27.1%, respectively. Revenue in North America was US$137.4 million, representing a decrease of 12.4% YoY.
Net profit was US$28.8 million, representing a decrease of 12.6% YoY.
FINAL DIVIDEND
The Board has resolved to declare a final dividend of HK$0.126 (inclusive of tax) per share for the year ended December 31, 2024.
KEY ACHIEVEMENTS
Confidence in Sisram's Core Platform Reaches an All-Time High reflected by remarkable market adoption of new products:
Alma Harmony™: An innovative, cutting-edge, multi-modal anti-aging platform designed to address multiple signs of aging across all skin types and diverse demographics. Following its record-breaking performance in the U.S. (H1 2024), Alma's new multiplatform was launched globally to unprecedented demand and better-than-expected market adoption, making it the most successful product launch in Sisram's history. The new platform also drives growth across the entire Harmony family.
Continuing its leadership in the hair removal segment, Alma launched the Special Edition of Soprano Titanium globally, supported by cross-territorial B2B and B2C campaigns. This new and improved flagship hair removal platform delivers 20% more energy while remaining virtually painless. According to Sapio Research, an independent global research agency, the new Soprano is the fastest hair removal treatment on the market compared to leading global laser hair removal brands.
The Company's quality management system has been successfully audited and found compliant with European MDR requirements, laying ...
